Relationship between upregulated oestrogen receptors and expression of growth factors in cultured, human, prostatic stromal cells exposed to estradiol or dihydrotestosterone

Prostate Cancer and Prostatic Diseases

Volumn 7, Issue 1, 2004, Pages 57-62

  Smith, P ^a   Rhodes, N P ^a   Ke, Y ^a   Foster, C S ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Androgen; Benign prostatic hyperplasia; Flow cytometry; Growth factors; Oestrogen receptors; Stroma; Tissue culture

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR; NERVE GROWTH FACTOR; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CELL GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; STROMA CELL; UPREGULATION;

DIHYDROTESTOSTERONE; ESTRADIOL; FLOW CYTOMETRY; GROWTH SUBSTANCES; HUMANS; MALE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, ESTROGEN; STROMAL CELLS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 1842477323     PISSN: 13657852     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.pcan.4500692     Document Type: Article

References (29)

1. Krieg M, Nass R, Tunn S. Effect of aging on endogenous level of 5 alpha-dihydrotestosterone, testosterone, estradiol and estrone in epithelium and stroma of normal and hyperplastic human prostate. J Clin Endocrinol Metab 1993; 77: 375-381.
2. Shibata Y et al. Changes in the endocrine environment of the human prostate transition zone with aging: Simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition. Prostate 2000; 42: 45-55.
3. Ehara H et al. Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry. Prostate 1995; 27: 304-313.
4. Kirschenbaum A et al. Estrogen receptor messenger RNA in human benign prostatic hyperplasia: Detection, localization and modulation with a long-acting gonadotrophin-releasing hormone agonist. J Androl 1994; 15: 528-533.
5. Kruithof-Dekker IG et al. Elevated estrogen receptor expression in human prostatic stromal cells by androgen ablation therapy. J Urol 1996; 156: 1194-1197.
6. Bodker A et al. Estrogen receptors in the human male prostatic urethra and prostate in prostatic cancer and benign prostatic hyperplasia. Scand J Urol Nephrol 1999; 33: 237-242.
7. Byrne RL, Leung H, Neal DE. Peptide growth factors in the prostate as mediators of stromal epithelial interaction. Br J Urol 1996; 77: 627-633.
8. Steiner MS. Role of peptide growth factors in the prostate - a review. Urology 1993; 42: 99-110.
9. Smith P et al. Upregulation of estrogen and androgen receptors modulate expression of FGF-2 and FGF-7 in human, cultured, prostatic stromal cells exposed to high concentrations of estradiol. Prost Cancer Prost Dis 2002; 5: 105-110.
10. Deshmukh N et al. Differential expression of acidic- and basic fibroblast growth factors in benign prostatic hyperplasia identified by immunohistochemistry. Br J Urol 1997; 80: 869-874.
11. Ittman M, Mansukhani A. Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. J Urol 1997; 157: 351-356.
12. Planz B et al. Regulation of keratinocyte growth factor and androgen receptor in epithelial cells of the human prostate. J Urol 2001; 166: 678-683.
13. Saez C et al. Expression of basic fibroblast growth factor and its receptors FGF R1 and FGF R2 in human benign prostatic hyperplasia treated with finasteride. Prostate 1999; 40: 83-88.
14. Sherwood ER et al. Basic fibroblast growth factor. A potential mediator of stromal growth in the human prostate. Endocrinology 1992; 130: 2955-2963.
15. Sinowatz F et al. Cellular localization of fibroblast growth factor 2 (FGF-2) in benign prostatic hyperplasia. Histol Histopathol 2000; 15: 475-481.
16. Boget S et al. Fibroblast growth factor receptor 1 (FGFR1) is overexpressed in benign prostatic hyperplasia whereas FGFR2-IIIC and FGFR3 are not. Eur J Endocrinol 2001; 145: 303-310.
17. Bonnet P et al. Benign prostatic hyperplasia and normal prostate aging: Differences in types I and II 5 alpha-reductase and steroid hormone receptor messenger ribonucleic acid (mRNA) levels, but not in insulin-like growth factor mRNA levels. J Clin Endocrinol Metab 1993; 77: 1203-1208.
18. Klinger HC et al. Regulation of prostatic stromal cell growth and function by transforming growth factor beta (TGF beta). Prostate 1999; 41: 110-120.
19. Lee C et al. Transforming growth factor beta in benign and malignant prostate. Prostate 1999; 39: 285-290.
20. Blanchere M et al. Transforming growth factor beta in the human prostate: Its role in stromal-epithelial interactions in non-cancerous cell culture. Prostate 2001; 46: 311-318.
21. Niu Y et al. Proliferation and differentiation of prostatic stromal cells. Br J Urol Int 2001; 87: 386-393.
22. Smith P et al. Prostatic stromal cell phenotype is directly modulated by norepinephrine. Urology 1998; 51: 663-670.
23. Collins AT, Robinson EJ, Neal DE. Benign prostatic stromal cells are regulated by basic fibroblast growth factor and transforming growth factor-beta 1. J Endocrinol 1996; 151: 315-322.
24. Planz B et al. Immunolocalization of the keratinocyte growth factor in benign and neoplastic human prostate and its relation to androgen receptor. Prostate 1999; 41: 233-242.
25. Djakiew D. Role of nerve growth factor-like protein in the paracrine regulation of prostate growth. J Androl 1992; 13: 476-487.
26. Pflug BR et al. Reduced expression of the low affinity nerve growth factor receptor in benign and malignant human prostate tissue and loss of expression in four human metastatic prostate tumor cell lines. Cancer Res 1992; 52: 5403-5406.
27. Gradini R et al. Nitric oxide synthases in normal and benign hyperplastic human prostate: Immunohistochemistry and molecular biology. J Pathol 1999; 189: 224-229.
28. Grande M et al. Estrogens increase the endothelial nitric oxide synthase (ec NOS) mRNA level in LNCaP human prostate carcinoma cells. Prostate 2000; 45: 232-237.
29. Levine AC et al. The effect of androgen, estrogen and growth factors on the proliferation of cultured fibroblasts derived from human fetal and adult prostates. Endocrinology 1992; 130: 2413-2419.